[DOI] [PubMed] [Google Scholar] 106.Jensterle M., Ferjan S., Leai L., et al
Overall, the effect of GLP-1RAs on muscle mass shows a high degree of heterogeneity in clinical trials: some studies report that lean body mass reduction accounts for 40% to 60% of total weight loss, while others indicate that the proportion of lean body mass reduction is approximately 15% or lower [50]
79 The promising benefits observed in major cardiovascular trials have sparked interest in their potential application for HF, particularly in patients with comorbid T2D or metabolic syndrome
doi:10.1093/micmic/ozad102 Mieczkowska A, Millar P, Chappard D, Gault VA, Mabilleau G
When you are dependent on a weekly injection, delays of even a few days can disrupt your protocol and potentially trigger withdrawal-like effects
GLP-1 medicines acting through weight loss-dependent and weight loss-independent mechanisms hold potential for suppression of tumorigenesis and reduction of rates of obesity-associated cancer
